While there are limitations, the promise of improved diabetes management, cardiovascular benefits, and new formulations places GLP-1 agonists at the forefront of diabetes care
Sold and shipped by Sabaforlife.com I have been on GLP-1 for a month now
The AACE/ACE, in contrast to the ADA, provides several monotherapy options that are recommended in the following order according to the strength of each recommendation: metformin, GLP-1 receptor agonist, SGLT-2 inhibitor, DPP-4 inhibitor, thiazolidinedione, -glucosidase inhibitor, and an insulin secretagogue (a sulfonylurea or meglitinide)
it can penetrate certain CNS regions, which are essential for appetite control and hunger and are not protected by the blood-brain barrier
July 8, 2023